| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 12/17/2009 | WO2009152053A1 Methods of treating alpha adrenergic mediated conditions using imidazoline derivates |
| 12/17/2009 | WO2009152052A1 Methods of treating alpha adrenergic mediated conditions |
| 12/17/2009 | WO2009151907A2 Compositions and methods for using cells to treat heart tissue |
| 12/17/2009 | WO2009151770A2 Colchicine solid-state forms; methods of making; and methods of use thereof |
| 12/17/2009 | WO2009151094A1 HUMAN β3 ADRENERGIC RECEPTOR LIGAND, AND FOOD OR PHARMACEUTICAL PRODUCT CONTAINING THE SAME |
| 12/17/2009 | WO2009150535A1 Dronedarone for the prevention of permanent atrial fibrillation |
| 12/17/2009 | WO2009150534A1 Dronedarone for the prevention of cardioversion |
| 12/17/2009 | WO2009150230A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer |
| 12/17/2009 | WO2009150214A2 Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease |
| 12/17/2009 | WO2009150007A1 Angiotensin ii receptor antagonists |
| 12/17/2009 | WO2009149880A1 Lactobacillus helveticus strains for producing hypotensive peptides |
| 12/17/2009 | WO2009149795A2 Heterocyclic cyclopropyl-substituted fxr binding compounds |
| 12/17/2009 | WO2009149496A1 Treatment of diabetes and complications thereof and related disorders |
| 12/17/2009 | WO2009149493A1 Novel receptor hetero-dimers/-oligomers |
| 12/17/2009 | WO2009066041A3 Derivatives of 1,2,4,5-tetrahydro-3h-benzazepines, preparation method therefor and pharmaceutical compositions containing same |
| 12/17/2009 | WO2009046834A3 Use of t140 and optionally retrocyclin-1 as therapeutic agents for the treatment of m. tuberculosis infections |
| 12/17/2009 | WO2009043481A3 Use of adrenomedullin 13-52 and optionally retrocyclin-1 as a therapeutic agent for the treatment of hcmv infections |
| 12/17/2009 | WO2009043439A3 Use of retrocyclin- 1 as a therapeutic agent for the treatment of hcmv infections |
| 12/17/2009 | WO2009043437A3 Use of t140 and optionally retrocyclin-1 as therapeutic agents for the treatment of m. tuberculosis infections |
| 12/17/2009 | WO2009040072A3 Use of angiotensin i as a therapeutic agent in the treatment of eg aids or tuberculosis |
| 12/17/2009 | WO2009040071A3 Use of cyclo-rgdfv and optionally angiotensin i as therapeutic agents in the treatment of eg aids or tuberculosis |
| 12/17/2009 | WO2009040029A3 Use of adrenomedullin as a therapeutic agent for the treatment of excessive angiogenesis |
| 12/17/2009 | WO2009040028A3 Use of casoxin c and optionally adrenomedullin as therapeutic agents for the treatment of excessive angiogenesis |
| 12/17/2009 | WO2009039968A3 Use of angiotensin iii as a therapeutic agent in the treatment of eg hbv infection |
| 12/17/2009 | WO2009039966A3 Use of nf-kappab inhibitor sn50 and optionally angiotensin iii as therapeutic agents in the treatment of eg hbv infection |
| 12/17/2009 | WO2009039957A3 Use of angiotensin ii as a therapeutic agent in the treatment of eg s. pneumoniae infection |
| 12/17/2009 | WO2009033796A8 Use of a peptide as a therapeutic agent |
| 12/17/2009 | WO2009033707A3 Use of retrocyclin-1 as a therapeutic agent for the treatment of hcmv infections |
| 12/17/2009 | WO2009033661A3 Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infections |
| 12/17/2009 | WO2008129308A3 Drug combination of beta 2 agonist and a progestin for the treatment of muscle loss |
| 12/17/2009 | US20090312706 Transdermal local anesthetic patch with injection port |
| 12/17/2009 | US20090312543 Pyrazole compounds useful as protein kinase inhibitors |
| 12/17/2009 | US20090312397 RNAi Modulation Of ApoB And Uses Thereof |
| 12/17/2009 | US20090312381 Substituted Arylimidazolone and Triazolone as Inhibitors of Vasopressin Receptors |
| 12/17/2009 | US20090312373 Methods for the treatment of cancer using piperlongumine and piperlongumine analogs |
| 12/17/2009 | US20090312369 Renin Inhibitors |
| 12/17/2009 | US20090312354 DHA Esters and Use Thereof In Treatment and Prevention of Cardiovascular Disease |
| 12/17/2009 | US20090312350 Compositions comprising balaglitazone and further antidiabetic compounds |
| 12/17/2009 | US20090312340 Use of ranolazine for the treatment of cardiovascular diseases |
| 12/17/2009 | US20090312322 Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3 |
| 12/17/2009 | US20090312320 Methods of treatment comprising the administration of haloaryl substituted aminopurines or compositions thereof |
| 12/17/2009 | US20090312319 Certain chemical entities, compositions and methods |
| 12/17/2009 | US20090312313 Compound having tgfbeta inhibitory activity and pharmaceutical composition comprising the same |
| 12/17/2009 | US20090312311 Combination of organic compounds |
| 12/17/2009 | US20090312307 Heterocyclo inhibitors of potassium channel function |
| 12/17/2009 | US20090312297 Methods for treating hypercholesterolemia and atherosclerosis |
| 12/17/2009 | US20090312286 Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors |
| 12/17/2009 | US20090312274 Nyasol and Analogs Thereof for the Treatment of Estrogen Receptor Beta-Mediated Diseases |
| 12/17/2009 | US20090312247 Natriuretic peptide related fragment in cardiovascular disease |
| 12/17/2009 | US20090312245 SRA binding protein |
| 12/17/2009 | US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 12/17/2009 | US20090311256 12 Human Secreted Proteins |
| 12/17/2009 | US20090311230 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 12/17/2009 | US20090311179 Selective Targeting of Apoptotic Cells |
| 12/17/2009 | DE10315030B4 Zyklische Peptide, Verfahren zu deren Herstellung und deren medizinische Verwendung Cyclic peptides, process for their preparation and to their medical use |
| 12/17/2009 | DE102008015432A1 Verwendung von Pirinixinsäure-Derivaten zur Hemmung der Prostaglandin E2 Synthese Use of Pirinixinsäure derivatives for the inhibition of prostaglandin E2 synthesis |
| 12/17/2009 | CA2727680A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer |
| 12/17/2009 | CA2727326A1 Dronedarone for the prevention of permanent atrial fibrillation |
| 12/17/2009 | CA2727223A1 Human .beta.3 adrenergic receptor ligand, and food or pharmaceutical product containing the same |
| 12/17/2009 | CA2727210A1 Dronedarone for the prevention of cardioversion |
| 12/17/2009 | CA2725611A1 Lactobacillus helveticus strains for producing hypotensive peptides |
| 12/17/2009 | CA2724919A1 Angiotensin ii receptor antagonists |
| 12/17/2009 | CA2724694A1 Compositions and methods for using cells to treat heart tissue |
| 12/17/2009 | CA2723270A1 Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease |
| 12/16/2009 | EP2133353A1 Novel adenine compound |
| 12/16/2009 | EP2133347A1 1-biarylazetidinone derivatives |
| 12/16/2009 | EP2133339A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure |
| 12/16/2009 | EP2133335A1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 12/16/2009 | EP2133330A1 Atropisomer of pyrrole derivative |
| 12/16/2009 | EP2133075A1 Use of dronedarone for the preparation of a medicament intended for the prevention of cardioversion |
| 12/16/2009 | EP2133074A1 Use of dronedarone for the preparation of a medicament intended for the prevention of permanent atrial fibrillation |
| 12/16/2009 | EP2133070A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |
| 12/16/2009 | EP2132313A1 Inhibitors of mrp4 for the treatment of vascular disorders |
| 12/16/2009 | EP2132187A2 Dual-acting antihypertensive agents |
| 12/16/2009 | EP2132176A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors |
| 12/16/2009 | EP2131864A2 Angiogenic composition |
| 12/16/2009 | EP2131844A1 PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
| 12/16/2009 | EP1429602B1 Methods for treating disorders using plant extracts |
| 12/16/2009 | EP1425028B1 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 12/16/2009 | CN101605793A Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
| 12/16/2009 | CN101605791A 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors |
| 12/16/2009 | CN101605776A 4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors |
| 12/16/2009 | CN101602790A Deep-sea fish skin collagen oligopeptide with function of reducing blood pressure and preparation method thereof |
| 12/16/2009 | CN101602768A Method for purifying sesamin and sesamolin |
| 12/16/2009 | CN101602754A Flavanone derivatives, preparation method and use thereof |
| 12/16/2009 | CN101602751A Preparation method of cinepazide maleate |
| 12/16/2009 | CN101602735A Preparation method of ligustrazine |
| 12/16/2009 | CN101602732A Derivative of acyl thiourea pyridine, method for preparing same and application thereof |
| 12/16/2009 | CN101602731A Metalloproteinase inhibitors |
| 12/16/2009 | CN101602709A Method for preparing cilnidipine used as dihydropyridine calcium antagonist |
| 12/16/2009 | CN101602652A Method for extracting resveratrol from moraceae plants |
| 12/16/2009 | CN101601859A Application of nattokinase in preparing cerebral protective agent type drugs |
| 12/16/2009 | CN101601854A Health care spirit |
| 12/16/2009 | CN101601845A Preparation method of pills for eliminating cardialgia |
| 12/16/2009 | CN101601813A Medicament for treating hypertensive renal damage and preparation method thereof |
| 12/16/2009 | CN101601811A Traditional Chinese medicine for curing hypertension |
| 12/16/2009 | CN101601796A Chinese medicinal fuming-steaming composition for treating arthralgia syndrome, and guiding medicament thereof |
| 12/16/2009 | CN101601795A Patch for treating hypertension |
| 12/16/2009 | CN101601775A Externally-applied traditional Chinese medicine preparation for curing cardio-cerebral respiratory circulatory system diseases and preparation method thereof |
| 12/16/2009 | CN101601774A Double-face external patch for treating hypertension |